Kadosaka, Takahide
Nagai, Toshiyuki http://orcid.org/0000-0002-1043-0608
Suzuki, Shinya
Sakuma, Ichiro
Akao, Masaharu
Yamashita, Takeshi
Anzai, Toshihisa
Okumura, Ken
,
Article History
Accepted: 25 March 2021
First Online: 8 April 2021
Declarations
:
: This study was performed in conformity to the ethical norms based on the Declaration of Helsinki (revised in 2008) and Ethical Guidelines for Medical and Health Research Involving Human Subjects (Public Notice of the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labor and Welfare in Japan, issued in 2014).
: Prior to enrolment, the contents of the study were explained to the patients using explanatory documents and consent documents, and written consent was obtained. If a patient withdrew consent during the observation period, all existing data collected from the patient were discarded.
: Dr. Kadosaka reports no conflict. Dr. Nagai received honoraria from Daiichi Sankyo Co., Ltd., a clinical research grant from JSPS KAKENHI Grant-in-Aid for Scientific Research, and research grants from the Takeda Science Foundation, the Japan Foundation for Aging and Health, and the Uehara Memorial Foundation. Dr. Suzuki received research funding from Daiichi-Sankyo and Mitsubishi-Tanabe. Dr. Sakuma reports no conflict. Dr. Akao received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare, and Daiichi-Sankyo. Dr. Yamashita received lecture fees from Bristol Myers Squibb, Daiichi-Sankyo, Bayer, Pfizer, Ono Pharmaceutical, and Toa Eiyo and research funding from Bayer and Daiichi Sankyo. Dr. Anzai received honoraria from Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., Boehringer Ingelheim Japan Co., Ltd., Bayer Pharmaceuticals Co., Ltd., and Bristol-Myers Squibb Co., Ltd.; clinical research grants from the Japan Agency for Medical Research and Development and Daiichi Sankyo Co., Ltd.; and scholarship funds from Biotronik Japan Co., Ltd., Medtronic Japan Co., Ltd., Win International Co., Ltd., Medical System Network Co., Ltd., and Hokuyaku Takeyama Holdings, Inc. Dr. Okumura received lecture fees from Daiichi-Sankyo, Boehringer Ingelheim, Bristol-Myers Squibb, Medtronic, and Johnson & Johnson.